Darcie was awarded one of 58 NIH New Innovator Awards for 2018. This award, from the NIH Common Fund, provides funding to extraordinarily creative scientists proposing highly innovative research to address major challenges in biomedical science. The grants are part of the NIH High-Risk, High-Reward Research Program, which supports ideas with potential for great impact in biomedical research from across the broad scope of the NIH.
“This program supports exceptionally innovative researchers who have the potential to transform the biomedical field,” said NIH Director Francis S. Collins, M.D., Ph.D.
The NIH Director’s New Innovator Award, established in 2007, supports unusually innovative research from early career investigators who are within 10 years of their final degree or clinical residency and have not yet received a research project grant or equivalent NIH grant.